Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Sunday, September 14, 2014

A Positive Impact on 3 Key Measures of Multiple Sclerosis (MS) Disease Activity Versus Placebo at Week 108 with AUBAGIO 14 mg1,2



Hear from Our Expert

Listen to an engaging and informative audio presentation by Dr. Steven Cavalier, Senior Medical Director for AUBAGIO at Genzyme, about the effects of AUBAGIO on MRI disease activity and what it may mean for your patients with MS.

AUBAGIO EFFECT ON MRI DISEASE ACTIVITY - Dr. Steven Cavalier
00:41/03:31



  To listen to this audio presentation, Please click here



Once-daily AUBAGIO® (teriflunomide) 14 mg tablets. AUBAGIO® is available in 14 mg and 7 mg tablets.







~~~~~~~~~~~~~~~~~~~~
 Keep CURRENT and up to date, with MS News and Information
Sign-up for emails 
.

WATCH OUR MS EDUCATIONAL VIDEOS by Topic, 

.


No comments: